Don founded Translational Software® to accelerate the use of molecular diagnostics. Prior to this he had a 14 year career at Microsoft, holding a variety of roles in providing Internet access to MSN, pioneering Virtual Private Networking products, and integrating Instant Messaging with Voice Over IP networks. Don founded the BioIT Alliance from within Microsoft to accelerate collaboration in translational research.
In November 2018, 23andMe became the first company authorized by the U.S. Food and Drug Administration (FDA) to offer direct-to-consumer pharmacogenomic reporting. Pharmacogenomic reports use genetic testing to